02Dec 2022
Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment

Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide and its incidence continues to rise, mostly owing to an increase in human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma. In this Review, the authors describe HPV-positive and HPV-negative HNSCC tumour microenvironments and discuss current and novel treatment modalities.

  • #oncology

Like

Save

Share